$TVTX news
The latest TVTX stock news: headlines, filings, AI summaries and sentiment for $TVTX, updated around the clock.
- Travere Therapeutics Projects $3 Billion in FILSPARI Sales by 2033 Amid Patent Extensions
- Travere Therapeutics Reports Q3 2026 Results Driven by FILSPARI Sales Growth
- Travere Therapeutics, Inc. - 10-Q Filing
- Travere Therapeutics Reports Q3 Revenue Beat Amid Non-GAAP EPS Miss
- Travere Therapeutics, Inc. - 8-K Filing
- Travere Therapeutics Scheduled to Report Q3 2026 Earnings
- Travere Therapeutics Appoints Bradley Campbell as New CEO
- Travere Therapeutics, Inc. - 8-K Filing
- Travere Therapeutics, Inc. - 8-K Filing
- Travere Therapeutics Enters Licensing Agreement Worth up to $1.1 Billion with Everest Medicines
- Travere Therapeutics, Inc. - 8-K Filing
- Travere Therapeutics, Inc. - 8-K Filing
- Travere Therapeutics, Inc. - 8-K Filing
- Director Exercises and Sells Shares at Travere Therapeutics
- Travere (TVTX) Q2 2025 Earnings Call Summary
- Travere Therapeutics Announces Q1 2026 Earnings Results and Filspari FDA Approval
- Travere Therapeutics Reports Q4 2025 Earnings with Strong Sales Growth and Improved Profitability
- Travere Therapeutics Reports Q2 2025 Earnings with Strong Sales Growth
- Travere Therapeutics Shares Rise 40.8% Following FDA Approval of Filspari
- Travere Therapeutics Director Sells Shares Amid Stock Rally